C4 THERAPEUTICS INC.
6.0400
07-11月-24 15:59:54
15 分の遅延
株式
+0.0700
+1.17%
本日の幅
5.9300 - 6.2500
ISIN
N/A
ソース
NASDAQ
-
C4 Therapeutics Announces First Patient Dosed in CFT8919 Clinical Trial
06 11 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
31 10 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28 10 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
15 10 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
09 10 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
30 9 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Delivery of Second Development Candidate to Biogen
10 9 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
08 9 2024 18:05:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Veteran Biotechnology Leader Stephen Fawell, Ph.D. to Board of Directors
03 9 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics to Participate in Upcoming September Investor Conferences
29 8 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
01 8 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
16 7 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics to Participate in the Virtual UBS Targeted Protein Degradation Day
08 7 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors
10 6 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
08 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
29 4 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum
09 4 2024 07:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >